Hyperkalemia in heart failure

Hyperkalemia is increasingly prevalent in the heart failure population as more people live with heart failure and comorbid conditions such as diabetes and chronic kidney disease. Furthermore, renin–angiotensin–aldosterone (RAAS) inhibitors are a key component of clinical therapy in these populations...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidhu, Kiran, Sanjanwala, Rohan, Zieroth, Shelley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams and Wilkins 2020
Materias:
HEART FAILURE: Edited by Haissam Haddad
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015190/
https://www.ncbi.nlm.nih.gov/pubmed/31833959
http://dx.doi.org/10.1097/HCO.0000000000000709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015190/
https://www.ncbi.nlm.nih.gov/pubmed/31833959
http://dx.doi.org/10.1097/HCO.0000000000000709

Ejemplares similares